Define the intended product first
Capsules, sachets and liquid products may have different requirements for the same active. Formulation teams should share the intended active amount and format, while procurement provides batch size, annual demand and delivery plans.
At Biontera, we consider ingredient supply alongside formulation consultancy and technical dossier review. The aim is to clarify how the proposed material fits the intended product from the outset.
- Target market, intended use and finished-product format.
- Active amount per serving and other ingredients.
- Planned production volume, initial batch and estimated annual requirement.
- Manufacturing conditions, packaging and target delivery date.
Review two complementary files
A batch CoA reports stated analytical results for a particular batch. The general product dossier covers broader information such as composition, specification, characterisation and available research. Product codes and manufacturer details should connect the two.
| Dossier topic | Information to review |
|---|---|
| Identity and composition | Active, carrier components, product code and manufacturer |
| Specification and CoA | Methods, units, limits and batch results |
| Liposomal characterisation | Method, sample identity and report date |
| Research | Tested formulation, dose and type of outcome |
| Manufacturing and storage | Conditions of use, packaging and stability information |
| Supply documentation | Origin, traceability and project-relevant supporting documents |
Source: FDA (2018) — Liposome Drug Products; technical reference for composition and characterisation; NCI — Characterisation methods and product-specific assessment
Add a serving calculation to the kilogram price
A cost assessment should consider nominal active content, intended serving and manufacturing usability together. Materials with different active percentages can then be compared using the same calculation basis.
A simple starting calculation divides the intended active amount by the active fraction to obtain the nominal ingredient requirement per serving. For illustration only, a material containing 20% active would require 500 mg to provide a nominal 100 mg of active. This is neither a recommended use level for a particular product nor a bioequivalence proposal.
Keep a decision record between sample and purchase
Record the product code and batch identity of the sample. Keep appearance, process-compatibility and analytical observations from formulation work in the same file. Clarifying the code, technical scope, packaging, lead time and documentation before ordering makes subsequent steps easier.
If research findings will be used in commercial communications, their relevance to the offered material and conditions in the target market require separate assessment. Reviewing a technical dossier does not guarantee a particular regulatory outcome.
What to send Biontera
Share a short project brief, requested actives, intended format and estimated annual demand. We can use this information to assess ingredient options, available documentation and the sample plan. Formulation development and application-dossier preparation needs can be considered within the same project.